{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-043530","form_type":"8-K","ticker":"SPWR","cik":"0001838987","company_name":"SunPower Inc.","filed_at":"2026-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.081418+00:00","generated_at":"2026-05-15T06:25:51.480628+00:00","sec_items":["4.02"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"SunPower restates 2025 interim financials due to material revenue, expense errors","bullets":["Company and Audit Committee determined prior Q1-Q3 2025 financials should no longer be relied upon.","Errors in revenue recognition, cost of revenues, sales commissions, and interest expense; linked to internal control weaknesses.","Preliminary Q1 2025: revenue decrease ~$5M, gross profit decrease ~$13M, net income decrease ~$4M.","Preliminary Q2 2025: revenue decrease ~$3M (13wks) and ~$8M (26wks); net loss increase ~$4M and ~$8M.","Preliminary Q3 2025: revenue decrease ~$5M (13wks) and ~$13M (39wks); net loss up ~$5M (39wks)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-043530","json":"https://secwatch.observer/filing/0001213900-26-043530.json","markdown":"https://secwatch.observer/filing/0001213900-26-043530.md","text":"https://secwatch.observer/filing/0001213900-26-043530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/ea0286264-8k_sunpower.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:25:51.480628+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"187069ce4c6a34e80af49bad5d4774c03572ad72","claim":"SunPower Inc. reported that prior financial statements should not be relied upon.","evidence_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001499275-26-000007","ticker":"GROO","company_name":"GROOVY COMPANY, INC.","filed_at":"2026-05-13T18:31:07+00:00","headline":"Groovy Company CEO Abajian exits May 1; accountant dismissed after SEC suspension; authorized common cut to 100M shares","event_type":"other_material","sec_items":["4.01","4.02","5.03","5.02","8.01","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001499275-26-000007","json":"https://secwatch.observer/filing/0001499275-26-000007.json","markdown":"https://secwatch.observer/filing/0001499275-26-000007.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000007/0001499275-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000007/groo-20250813_8k.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"(a) Dismissal of Previous Independent Registered Public Accounting Firm. On August 13, 2025, the Board of Directors of Groovy Company, Inc.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1499275/000149927526000007/0001499275-26-000007-index.htm"}},{"accession":"0001193125-26-218141","ticker":"HUBG","company_name":"Hub Group, Inc.","filed_at":"2026-05-12T11:04:45+00:00","headline":"Hub Group restates 2023 and 2024 financials; premature revenue recognition cited","event_type":"other_material","sec_items":["4.02"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-218141","json":"https://secwatch.observer/filing/0001193125-26-218141.json","markdown":"https://secwatch.observer/filing/0001193125-26-218141.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/940942/000119312526218141/0001193125-26-218141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/940942/000119312526218141/d146211d8k.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"On May 11, 2026, the Audit Committee of the Board of Directors of Hub Group, Inc. (the “Company”), following discussion with and upon the recommendation of management, concluded that the previously issued audited consolidated financial statements of the Company as of and for each of the years ended December 31, 2024 (the “2024 Financial Statements”) and 2023 (the “2023 Financial Statements”) included in the Company’s Annual Reports on Form 10-K filed on February 25, 2025 and February 27, 2024, respectively, were in each case materially misstated and should no longer be relied upon.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/940942/000119312526218141/0001193125-26-218141-index.htm"}},{"accession":"0001437749-26-013891","ticker":"SDEV","company_name":"Stablecoin Development Corp","filed_at":"2026-04-29T23:59:59+00:00","headline":"SDEV restates 2025 financials; warrant error increases net loss from $22.1M to $630.8M","event_type":"other_material","sec_items":["4.02"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013891","json":"https://secwatch.observer/filing/0001437749-26-013891.json","markdown":"https://secwatch.observer/filing/0001437749-26-013891.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1389545/000143774926013891/0001437749-26-013891-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1389545/000143774926013891/nby20260428_8k.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"On April 27, 2026, the audit committee of the board of directors and management of the Company concluded that the Company’s previously issued audited consolidated financial statements for the year ended December 31, 2025, should no longer be relied upon because of an error in the Company’s accounting relating to certain outstanding pre-funded warrants issued on October 16, 2025","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774926013891/0001437749-26-013891-index.htm"}},{"accession":"0001437749-26-007981","ticker":"GNE","company_name":"Genie Energy Ltd.","filed_at":"2026-03-12T23:59:59+00:00","headline":"Genie Energy restates 2023-2025 financials; net income increases ~$55.6M combined","event_type":"other_material","sec_items":["4.02","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-007981","json":"https://secwatch.observer/filing/0001437749-26-007981.json","markdown":"https://secwatch.observer/filing/0001437749-26-007981.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528356/000143774926007981/0001437749-26-007981-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528356/000143774926007981/gne20260312_8k.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"should not be relied upon and require restatement","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1528356/000143774926007981/0001437749-26-007981-index.htm"}},{"accession":"0001213900-26-023054","ticker":"ABVC","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2026-03-03T23:59:59+00:00","headline":"ABVC BioPharma concludes Q3 2025 financials unreliable; total assets surge 179% to $21.06M","event_type":"other_material","sec_items":["2.02","4.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-023054","json":"https://secwatch.observer/filing/0001213900-26-023054.json","markdown":"https://secwatch.observer/filing/0001213900-26-023054.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026023054/0001213900-26-023054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026023054/ea0279143-8k_abvc.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"atters disclosed in this Item 4.02 with its independent registered public accounting firm, Simon & Edward, LLP. Due to the above, the Company determined that it has\na material weakness in its internal controls over financial reporting and shall include such determination in its Annual Report on Form","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390026023054/0001213900-26-023054-index.htm"}},{"accession":"0001493152-26-008442","ticker":"GTBP","company_name":"GT Biopharma, Inc.","filed_at":"2026-03-02T23:59:59+00:00","headline":"GT Biopharma restates Q2/Q3 2025 financials; Greenshoe Rights liability misclassified","event_type":"other_material","sec_items":["4.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008442","json":"https://secwatch.observer/filing/0001493152-26-008442.json","markdown":"https://secwatch.observer/filing/0001493152-26-008442.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315226008442/0001493152-26-008442-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315226008442/form8-k.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"on March 1, 2026, the audit committee of the Company’s board of directors, after discussion with the Company’s management and Weinberg, concluded that this resulted in an error in the Company’s interim quarterly financial statements as originally reported in the Company’s Quarterly Reports on Form 10-Q for the quarterly periods ended June 30, 2025, and September 30, 2025, which may no longer be relied upon.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315226008442/0001493152-26-008442-index.htm"}},{"accession":"0001628280-26-013214","ticker":"CORZ","company_name":"Core Scientific, Inc./tx","filed_at":"2026-03-02T23:59:59+00:00","headline":"Core Scientific restates financials for multiple periods due to improper asset capitalization, reports Q4 2025 results","event_type":"other_material","sec_items":["2.02","4.02","7.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-013214","json":"https://secwatch.observer/filing/0001628280-26-013214.json","markdown":"https://secwatch.observer/filing/0001628280-26-013214.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/0001628280-26-013214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/core-20260302.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"On February 25, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of the Company, in consultation with management, determined that the Company’s consolidated financial statements for the three and six months ended June 30, 2024, the three and nine months ended September 30, 2024, the year ended December 31, 2024, the three months ended March 31, 2025, the three and six months ended June 30, 2025, and the three and nine months ended September 30, 2025 (the “Non-Reliance Periods”) should no longer be relied upon due to the accounting errors described below.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1839341/000162828026013214/0001628280-26-013214-index.htm"}},{"accession":"0001804745-26-000015","ticker":"DRVN","company_name":"Driven Brands Holdings Inc.","filed_at":"2026-02-25T23:59:59+00:00","headline":"Driven Brands Restates Financials for FY2023, FY2024, and Interim 2025 Periods","event_type":"other_material","sec_items":["4.02","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: auditor_change","same SEC item: 4.02","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001804745-26-000015","json":"https://secwatch.observer/filing/0001804745-26-000015.json","markdown":"https://secwatch.observer/filing/0001804745-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1804745/000180474526000015/0001804745-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1804745/000180474526000015/drvn-20260225.htm"},"side_by_side_evidence":{"fact_type":"auditor_change","source_excerpt":"aterial errors and should no longer be relied upon and should be restated. These material errors related to the recognition of revenue","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1838987/000121390026043530/0001213900-26-043530-index.htm","comparable_excerpt":"On February 23, 2026, the Audit Committee of the Board of Directors, after consultation with the Company’s management, concluded there were material errors in our previously issued consolidated financial statements for the fiscal year ended December 28, 2024 (“fiscal year 2024”) and the fiscal year ended December 30, 2023 (“fiscal year 2023”) contained in the Company’s Annual Report on Form 10-K for the fiscal year 2024, and in our previously issued unaudited condensed consolidated financial statements for each of the quarterly and year-to-date periods within fiscal year 2024 as well as the quarterly and year-to-date periods for the periods ended September 27, 2025, June 28, 2025 and March 29, 2025, and concluded that such financial statements should not be relied upon and required restatement (the “Restatement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1804745/000180474526000015/0001804745-26-000015-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}